Taysha Gene Therapies, Inc. (TSHA) 8-K filings
- Ticker
- TSHA (Nasdaq)
- SEC CIK
- 1806310
- Industry (SIC)
- 2836 Biological Products, (No Diagnostic Substances)
- Incorporated in
- DE
- All filings
- SEC EDGAR
Recent 8-Ks
| Accepted (ET) | Form | Items | Filing |
|---|---|---|---|
| 2026-11-12 07:38 | 8-K | 2.02 Earnings release | Details |